Study #2022-0915
Phase II randomized-registry embedded study of lymphoscintigraphy for Oropharyngeal Neoplasms to enable risk-adapted nodal guidance for robotic surgery and/or radiotherapy (LONE-RANGR2)
MD Anderson Study Status
Enrolling
Treatment Agent
Description
To test a new radiation treatment design based on where your cancer is located. Most participants with oropharyngeal cancer are treated with radiation to both sides of the neck. However, for participants with oropharyngeal cancer on one side of the neck, receiving radiation to both sides of the neck may result in increased side effects and radiation exposure. This study is testing the safety and effectiveness of an approach that involves radiation to only one side of the neck in an effort to reduce the overall amount of radiation given and decrease the amount of side effects you may experience.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Oropharyngeal Neoplasms;Robotic Surgery and/or Radiotherapy;Lymphoscintigraphy
Study phase:
Phase II
Physician name:
David Rosenthal
Department:
Radiation Oncology
For general questions about clinical trials:
1-877-632-6789
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.